50 days at 20mg
Methandrostenolone was first reported in the literature in 1955; and soon released in 1958 by Ciba Pharmaceuticals to the US prescription market under the drug name Dianabol. A derivative of testosterone, the compound has been modified to reduce the androgenic and preserve the anabolic properties. Historically, it has been the most commonly used C-17a alkylated oral steroid for physique enhancing purposes but does have its history deep rooted in medical prescriptions also. Originally developed alongside Dr John Ziegler; a physician for US Olympic teams, in hopes of reducing competition to Russia who were already utilizing testosterone with their athletes, Methandrostenolone brought a new dynamic as a compound with lower androgenicity but with retained anabolic properties, soon causing advancements in competitive sports.